EVALUATION OF A NEW CONCENTRATE FOR TREATMENT OF FACTOR 9 DEFICIENCY

[1] AGGELER PM, PERSONAL COMMUNICATI

[2] PREPARATION FOR THERAPEUTIC USE OF A CONCENTRATE OF FACTOR 9 CONTAINING ALSO FACTORS 2 7 AND X [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1967, 13 (04) : 568 - &

[3] BIDWELL E, 1966, TREATMENT HAEMOPHILI, P62

[4] BIGGS R, 1962, HUMAN BLOOD COAGULAT, P252

[5] BIGGS R, 1966, TREATMENT HAEMOPH ED, P62

[6] BIGGS R, 1966, TREATMENT HAEMOPHILI, P222

[7] DEN OTTOLANDER G J, 1955, Ned Tijdschr Geneeskd, V99, P2037

[8] ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY ( FIBRINOLYSIS ) IN PATIENTS WITH HEPATIC CIRRHOSIS - ITS CAUSE + CONSEQUENCES [J]. JOURNAL OF CLINICAL INVESTIGATION, 1964, 43 (04) : 681 - &

[9] HOAG SM, 1968, 12 C INT SOC HEM, P174

[10] JACOBSSON K, 1955, SCAND J CLIN LAB S14, V7, P7

[1] AGGELER PM, PERSONAL COMMUNICATI

[2] PREPARATION FOR THERAPEUTIC USE OF A CONCENTRATE OF FACTOR 9 CONTAINING ALSO FACTORS 2 7 AND X [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1967, 13 (04) : 568 - &

[3] BIDWELL E, 1966, TREATMENT HAEMOPHILI, P62

[4] BIGGS R, 1962, HUMAN BLOOD COAGULAT, P252

[5] BIGGS R, 1966, TREATMENT HAEMOPH ED, P62

[6] BIGGS R, 1966, TREATMENT HAEMOPHILI, P222

[7] DEN OTTOLANDER G J, 1955, Ned Tijdschr Geneeskd, V99, P2037

[8] ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY ( FIBRINOLYSIS ) IN PATIENTS WITH HEPATIC CIRRHOSIS - ITS CAUSE + CONSEQUENCES [J]. JOURNAL OF CLINICAL INVESTIGATION, 1964, 43 (04) : 681 - &

[9] HOAG SM, 1968, 12 C INT SOC HEM, P174

[10] JACOBSSON K, 1955, SCAND J CLIN LAB S14, V7, P7